ACE2 receptor
Pro Research Analysisby 
Searched over 200M research papers for "ACE2 receptor"
ACE2 Receptor: Role in SARS-CoV-2 Infection and Human Physiology
ACE2 Receptor as the Entry Point for SARS-CoV-2
The ACE2 (angiotensin-converting enzyme 2) receptor is the main entry point for SARS-CoV-2, the virus responsible for COVID-19. The virus uses its spike (S) glycoprotein to bind to ACE2 on the surface of human cells, especially in the airway and lung epithelium, allowing the virus to enter and infect the cell 1235+5 MORE. This interaction is highly specific, with the receptor-binding domain of the viral spike protein showing a strong affinity for human ACE2, which may explain the high infectivity of SARS-CoV-2 210.
Distribution and Regulation of ACE2 Expression
ACE2 is widely expressed in many tissues, including the lungs, heart, blood vessels, gut, kidneys, brain, and adipose tissue 2345+2 MORE. Within the lungs, ACE2 is especially present in type II pneumocytes and macrophages 35. The expression of ACE2 can be influenced by factors such as age, sex, comorbidities (like hypertension, diabetes, and cardiovascular disease), medications (such as anti-hypertensives), and environmental factors 478. Notably, ACE2 is also an interferon-stimulated gene in human airway epithelial cells, meaning its expression can be increased in response to viral infections and inflammation .
ACE2 and the Renin-Angiotensin System (RAS)
Beyond serving as a viral receptor, ACE2 plays a crucial role in regulating the renin-angiotensin system (RAS), which controls blood pressure, fluid balance, and inflammation 2367+1 MORE. ACE2 acts as a negative regulator by converting angiotensin II, a molecule that promotes vasoconstriction and inflammation, into angiotensin 1-7, which has protective effects such as vasodilation and anti-inflammatory actions 2369. This balance is important for cardiovascular and lung health.
Impact of SARS-CoV-2 on ACE2 Function and Disease Severity
When SARS-CoV-2 binds to ACE2 and enters the cell, it leads to a reduction in ACE2 on the cell surface, disrupting its protective functions 2369. This downregulation can result in increased angiotensin II activity, promoting inflammation, thrombosis, and tissue injury, especially in the lungs 369. People with pre-existing conditions that already have lower ACE2 levels, such as older adults or those with hypertension, diabetes, or cardiovascular disease, may be more vulnerable to severe COVID-19 due to further loss of ACE2 function after infection 3478.
Therapeutic Implications Targeting ACE2
Understanding the role of ACE2 in both viral entry and RAS regulation has led to the exploration of therapies that target this pathway. Potential strategies include using recombinant human ACE2, angiotensin 1-7 analogs, Mas receptor agonists, and inhibitors that block the interaction between the viral spike protein and ACE2 2369+1 MORE. These approaches aim to restore the protective effects of ACE2 or prevent the virus from entering cells.
Conclusion
The ACE2 receptor is central to both the entry of SARS-CoV-2 into human cells and the regulation of key physiological processes. Its widespread expression, regulation by various factors, and dual role in infection and homeostasis make it a critical focus for understanding COVID-19 pathogenesis and developing effective treatments 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic